Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The triple-receptor mechanism, particularly the added glucagon receptor activation, accelerates results
Contraindication Signals Standard conservative practice excludes anyone with active gastrointestinal disease, type 1 diabetes, prior pancreatitis, medullary thyroid carcinoma history, or active cancer from any tirzepatide protocol
Notably, this low dose outperformed even some existing obesity medications at the time, without the troublesome side effects
This technical evolution allows for a level of personalization previously unseen in the category
Semaglutide and Tirzepatide doses must gradually increase over time to reduce gastrointestinal side effects
US$ 27.16
US$ 28.92
US$ 28.08
